Profound Medical

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PROF and other ETFs, options, and stocks.

About PROF

Profound Medical Corp. is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the ablation of diseased tissue utilizing its platform technologies. The firm’s product, the TULSA-PRO system, combines real-time MRI, robotically driven transurethral sweeping action/thermal ultrasound, and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue.

CEO

Arun S. Menawat

CEOArun S. Menawat

Employees

142

Employees142

Headquarters

Mississauga, Ontario

HeadquartersMississauga, Ontario

Founded

2008

Founded2008

Employees

142

Employees142

PROF Key Statistics

Market cap

300.86M

Market cap300.86M

Price-Earnings ratio

-6.15

Price-Earnings ratio-6.15

Dividend yield

—

Dividend yield—

Average volume

328.88K

Average volume328.88K

High today

$8.60

High today$8.60

Low today

$8.18

Low today$8.18

Open price

$8.39

Open price$8.39

Volume

118.26K

Volume118.26K

52 Week high

$8.95

52 Week high$8.95

52 Week low

$3.76

52 Week low$3.76

Stock Snapshot

As of today, Profound Medical(PROF) shares are valued at $8.22. The company's market cap stands at 300.86M, with a P/E ratio of -6.15.

On 2026-01-17, Profound Medical(PROF) stock moved within a range of $8.18 to $8.60. With shares now at $8.22, the stock is trading +0.5% above its intraday low and -4.4% below the session's peak.

Trading volume for Profound Medical(PROF) stock has reached 118.26K, versus its average volume of 328.88K.

Over the past 52 weeks, Profound Medical(PROF) stock has traded between a high of $8.95 and a low of $3.76.

People also own

Based on the portfolios of people who own PROF. This list is generated using Robinhood data, and it’s not a recommendation.